SDOX, a Doxorubicin (DOX) prodrug, selectively releases the active agent, DOX, in tumor cells with elevated glutathione (GSH) levels, thereby reducing inadvertent adverse effects on healthy tissues while maintaining therapeutic efficacy [1].
Molecular Weight:
1324.63
CAS Number:
[2921601-78-5]
Formula:
C69H97NO20S2
Target:
Topoisomerase
* VAT and and shipping costs not included. Errors and price changes excepted
